For example, EGCG has been shown to induce apoptosis in breast cancer by activating apoptosis-related proteins, such as caspase 3 and 9, and in cholangiocarcinoma by inducing apoptotic molecular signals, such as Bax and cytochrome c [141]. This evidence concerns the gene CASP3 and breast carcinoma.